secwatch.observer — SEC 8-K summary
======================================

Issuer:     SenesTech, Inc. (SNES)
CIK:        0001680378
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001628280-23-017548
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SenesTech Q1 revenue up 19% to $233K; net loss narrows to $2.0M
---------------------------------------------------------------

- Revenue $233K vs $195K YoY (+19%); e-commerce sales grew 54% and comprised 45% of product sales.
- Gross profit margin 39.6% (57.8% excluding defective inventory scrapping); net loss $2.0M vs $2.3M.
- Adjusted EBITDA loss $1.8M; cash $2.7M at quarter end; subsequent $1.5M registered direct offering in April 2023.
- Signed distribution agreements with Veseris and Target Specialty Products; TIME Magazine feature on ContraPest.
- Biosynthetic triptolide development with TriptoBIO; soft bait candidate progressing with Liphatech.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680378/000162828023017548/0001628280-23-017548-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680378/000162828023017548/snes-20230511.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-017548

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer